Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Depression and sleep disturbances in patients with multiple sclerosis and correlation with associated fatigue.
Most Scottish neurologists do not apply the 2010 McDonald criteria when diagnosing multiple sclerosis.
Mechanisms of pain in multiple sclerosis: A combined clinical and neurophysiological study.
The switch between relapse and remission in multiple sclerosis: Continuous inflammatory response balanced by Th1 suppression and neurotrophic factors.
CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.
Gene profile analysis implicates Klotho as an important contributor to aging changes in brain white matter of the rhesus monkey.
TRPM2 Cation Channels Modulate T Cell Effector Functions and Contribute to Autoimmune CNS Inflammation.
Update in pediatric optic neuritis.
Anesthesia for the obstetric patient with multiple sclerosis.
Medication use in a large international sample of people with multiple sclerosis: associations with quality of life, relapse rate and disability.
Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination.
Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases.
Quality of life among people with multiple sclerosis: Replication of a three-factor prediction model.
Improving adherence to injectable disease-modifying drugs in multiple sclerosis.
Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
[Acute disseminated encephalomyelitis and multiple sclerosis: open questions of differential diagnosis demonstrated by the example of a clinical case.]
Integrity of the anterior visual pathway and its association with ambulatory performance in multiple sclerosis.
Multiple sclerosis: Activation of cortical microglia linked to level of disability in patients with multiple sclerosis.
Immune surveillance and response to JC virus infection and PML.
Validating archetypes for the Multiple Sclerosis Functional Composite.
Chronic illness and return to work: a social cognitive perspective.
Multiple sclerosis: Managing patients in primary care.
Optic neuritis and the evaluation of visual impairment in multiple sclerosis.
Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS).
P wave duration and dispersion and QT interval in multiple sclerosis.
Pages
« first
‹ previous
…
382
383
384
385
386
387
388
389
390
…
next ›
last »